Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda
- PMID: 32019543
- PMCID: PMC7001317
- DOI: 10.1186/s12889-020-8302-z
Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda
Erratum in
-
Correction to: Health system factors influencing uptake of human papilloma virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda.BMC Public Health. 2020 Apr 15;20(1):491. doi: 10.1186/s12889-020-8348-y. BMC Public Health. 2020. PMID: 32295557 Free PMC article.
Abstract
Background: Globally, cervical cancer is the fourth most common cancer in women with more than 85% of the burden in developing countries. In Uganda, cervical cancer has shown an increase of 1.8% per annum over the last 20 years. The availability of the Human Papillomavirus (HPV) vaccine presents an opportunity to prevent cervical cancer. Understanding how the health system influences uptake of the vaccine is critical to improve it. This study aimed to assess how the health systems is influencing uptake of HPV vaccine so as to inform policy for vaccine implementation and uptake in Mbale district, Eastern Uganda.
Methods: We conducted a cross sectional study of 407 respondents, selected from 56 villages. Six key informant interviews were conducted with District Health Officials involved in implementation of the HPV vaccine. Quantitative data was analyzed using Stata V.13. Prevalence ratios with their confidence intervals were reported. Qualitative data was audio recorded, transcribed verbatim and analyzed using MAXQDA V.12, using the six steps of thematic analysis developed by Braun and Clarke.
Results: Fifty six (14%) of 407 adolescents self-reported vaccine uptake. 182 (52.3%) of 348 reported lack of awareness about the HPV vaccine as the major reason for not having received it. Receiving vaccines from outreach clinics (p = 0.02), having many options from which to receive the vaccine (p = 0.02), getting an explanation on possible side-effects (p = 0.024), and receiving the vaccine alongside other services (p = 0.024) were positively associated with uptake. Key informants reported inconsistency in vaccine supply, inadequate training on HPV vaccine, and the lack of a clear target for HPV vaccine coverage as the factors that contribute to low uptake.
Conclusion: We recommend training of health workers to provide adequate information on HPV vaccine, raising awareness of the vaccine in markets, schools, and radio talk shows, and communicating the target to health workers. Uptake of the HPV vaccine was lower than the Ministry of Health target of 80%. We recommend training of health workers to clearly provide adequate information on HPV vaccine, increasing awareness about the vaccine to the adolescents and increasing access for girls in and out of school.
Keywords: Adolescent girls; Cervical cancer; Health system; Human papillomavirus vaccine; Low income country; Uptake.
Conflict of interest statement
The authors declare that they have no competing interest.
Figures
Similar articles
-
Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.BMC Womens Health. 2023 Jul 8;23(1):362. doi: 10.1186/s12905-023-02511-z. BMC Womens Health. 2023. PMID: 37420225 Free PMC article.
-
Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda.Pan Afr Med J. 2018 Nov 15;31:184. doi: 10.11604/pamj.2018.31.184.14801. eCollection 2018. Pan Afr Med J. 2018. PMID: 31086634 Free PMC article.
-
Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.Afr Health Sci. 2015 Mar;15(1):33-41. doi: 10.4314/ahs.v15i1.5. Afr Health Sci. 2015. PMID: 25834528 Free PMC article.
-
Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.BMC Public Health. 2024 Mar 18;24(1):842. doi: 10.1186/s12889-024-18141-5. BMC Public Health. 2024. PMID: 38500046 Free PMC article.
-
The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.Adv Ther. 2011 Aug;28(8):615-39. doi: 10.1007/s12325-011-0045-x. Epub 2011 Aug 1. Adv Ther. 2011. PMID: 21818672 Review.
Cited by
-
Reasons given for non-vaccination and under-vaccination of children and adolescents in sub-Saharan Africa: A systematic review.Hum Vaccin Immunother. 2022 Nov 30;18(5):2076524. doi: 10.1080/21645515.2022.2076524. Epub 2022 Jun 16. Hum Vaccin Immunother. 2022. PMID: 35709342 Free PMC article.
-
Gaps in measles vaccination coverage in Kasese district, Western Uganda: results of a qualitative evaluation.BMC Infect Dis. 2022 Jul 4;22(1):589. doi: 10.1186/s12879-022-07579-w. BMC Infect Dis. 2022. PMID: 35787247 Free PMC article.
-
Uptake of human papillomavirus vaccination and its associated factors among adolescents in Gambella town, Southwest, Ethiopia: a community-based cross-sectional study.BMJ Open. 2023 Sep 5;13(9):e068441. doi: 10.1136/bmjopen-2022-068441. BMJ Open. 2023. PMID: 37669848 Free PMC article.
-
Uptake of Human Papilloma Virus vaccine among young women living in fishing communities in Wakiso and Mukono districts, Uganda.PLOS Glob Public Health. 2024 Apr 18;4(4):e0003106. doi: 10.1371/journal.pgph.0003106. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38635646 Free PMC article.
-
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis.EClinicalMedicine. 2021 Apr 17;34:100836. doi: 10.1016/j.eclinm.2021.100836. eCollection 2021 Apr. EClinicalMedicine. 2021. PMID: 33997733 Free PMC article.
References
-
- International Agency for Research on Cancer. 2008.
-
- WHO . Human papillomavirus infection and cervical cancer WHO. 2010.
-
- WHO . Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the united republic of Tanzania and Zambia. Geneva: World Health Organization. : African Population and Health Research Center, International Agency for Research on Cancer; 2012.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical